Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
West Virginia University
West Virginia University
University of Manitoba
National Institutes of Health Clinical Center (CC)
Boston Children's Hospital
Alexandria University
Assistance Publique - Hôpitaux de Paris
Shanghai Jiao Tong University School of Medicine
Thomas Jefferson University
University of Zurich
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Augusta University
Instituto Nacional de Cancerologia de Mexico
Universitaire Ziekenhuizen KU Leuven
University of Nebraska
Universitaire Ziekenhuizen KU Leuven
Centre Hospitalier Universitaire de Nice
Rush University Medical Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Paris 13
National Institutes of Health Clinical Center (CC)
Duke University
M.D. Anderson Cancer Center
Children's Oncology Group
West Virginia University
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Children's Hospital of Philadelphia
National Institutes of Health Clinical Center (CC)
Indonesia University
Amsterdam UMC, location VUmc
Cellerant Therapeutics
Wake Forest University Health Sciences
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
German CLL Study Group
Alliance for Clinical Trials in Oncology
Assistance Publique - Hôpitaux de Paris
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
SWOG Cancer Research Network
National Hematological Society, Russia
M.D. Anderson Cancer Center
Janssen Korea, Ltd., Korea
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mashhad University of Medical Sciences
National Cancer Institute (NCI)
Janssen Korea, Ltd., Korea
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)